The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)

Exclusion criteria

• ✕. Acute coronary syndromes or active ischemic heart disease (as assessed by the PI using troponin and ECG)
• ✕. Cardiac ejection fraction \< 40% (if known);
• ✕. Need for multiple-dose vasopressors to support blood pressure (single dose vasopressors, such as Levophed™ ≤ 0.1 mcg/kg/min are allowed);
• ✕. Cardiogenic pulmonary edema as the etiology of the current respiratory distress;
• ✕. Evidence of myocarditis or pericarditis;